18 Biggest Mid-Day Losers For Tuesday
- BioScrip Inc (NASDAQ: BIOS) tumbled 47.9 percent to $1.36. BioScrip reported a Q3 loss from continuing operations of $0.12 per share on revenue of $224.5 million. The company also raised its FY16 sales outlook.
- OneMain Holdings Inc (NYSE: OMF) dropped 38.5 percent to $16.97 on weak Q3 earnings. Several analysts downgraded the stock following results.
- Hertz Global Holdings, Inc (NYSE: HTZ) shares declined 31.8 percent to $24.37 after the company reported weaker-than-expected results for the third quarter and provided downbeat forecast for the full year.
- CGG SA (ADR) (NYSE: CGG) shares dropped 28.4 percent to $18.56. CGG posted a Q3 loss of $3.95 per share on revenue of $264 million.
- Kindred Healthcare, Inc. (NYSE: KND) shares fell 26.3 percent to $6.40 after the company reported wider Q3 loss and announced plans to exit the skilled nursing facility business.
- Rockwell Medical Inc (NASDAQ: RMTI) shares fell 25.2 percent to $4.24. Rockwell Medical reported a Q3 loss of $0.09 per share on revenue of $12.8 million.
- L.B. Foster Co (NASDAQ: FSTR) declined 24.4 percent to $9.60. L.B. Foster reported a Q3 loss of $6 million on revenue of revenue of $100.3 million.
- American Public Education, Inc. (NASDAQ: APEI) fell 23.6 percent to $15.35. American Public Education reported Q3 net income of $326,000 on revenue of $73.8 million.
- Valeant Pharmaceuticals Intl Inc (NYSE: VRX) dropped 22.5 percent to $14.83 as the company reported weaker-than-expected earnings for its third quarter and lowered its full year fiscal 2016 guidance.
- Model N Inc (NYSE: MODN) fell 22.3 percent to $7.85. Model N reported a FQ4 loss of $7.8 million.
- hhgregg, Inc. (NYSE: HGG) declined 19.5 percent to $1.40. Hhgregg reported a FQ2 loss of $18.4 million.
- Depomed Inc (NASDAQ: DEPO) shares dropped 19 percent to $18.55 in pre-market trading following Q3 results. Depomed reported a Q3 loss of $0.21 per share on revenue of $110.524 million.
- Cempra Inc (NASDAQ: CEMP) shares declined 13.9 percent to $5.90. Morgan Stanley downgraded Cempra from Overweight to Underweight and lowered the price target from $35.00 to $5.00.
- CVS Health Corp (NYSE: CVS) shares declined 13.2 percent to $72.33. CVS delivered better than expected EPS for the third quarter though revenue missed. However, the company offered downbeat guidance for the fourth quarter and next year.
- Momo Inc (ADR) (NASDAQ: MOMO) dropped 12.8 percent to $23.28 following strong Q3 earnings report and guidance.
- Gravity Co., LTD. (ADR) (NASDAQ: GRVY) declined 12 percent to $13.10 after gaining 13.09 percent on Monday.
- Nevro Corp (NYSE: NVRO) shares fell 5.8 percent to $84.00. Nevro reported a Q3 loss of $0.14 per share on revenue of $60.9 million. The company also raised its FY16 revenue guidance.
- D.R. Horton, Inc. (NYSE: DHI) dropped 5.2 percent to $27.85 after the company reported downbeat earnings for the fourth quarter.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets
